Please enable JS

FDA public Meeting Statement on Abuse Deterrent Opioid Formulations

10/ 30

ARTICLE DETAILS

AUTHOR: 50SN Staff

DATE: Oct 30, 2014

TAGS:

SHARE ON: Twitter - Facebook - LinkedIn

FDA public Meeting Statement on Abuse Deterrent Opioid Formulations

“On behalf of the Global Healthy Living Foundation, I want to thank the FDA for its commitment to taking input from a diverse set of stakeholders. GHLF is a 501(c)(3) patient group working to improve the quality of life for people with chronic disease, often focusing on those least able to advocate for themselves. We represent approximately 74,000 patients and caregivers nationwide who are in pain.”

FDA public Meeting Statement on Abuse Deterrent Opioid Formulations 10-30-14


 

Font Resize